Subscribe Now

By entering these details you are signing up to receive our newsletter.

Answer with a number. This checks you are not a robot.

Amy and Friends charity founder shares rare disease clinic expertise in Japan

Jayne Hughes BEM, from Mold, North Wales, joins international clinicians and scientists at a symposium for DNA repair disorders in Nagasaki to help improve care for families affected by rare conditions.

Jayne Hughes BEM, from Mold, founder of the charity Amy and Friends, has travelled to Nagasaki, Japan, alongside clinicians and scientists from around the world to share experience of developing specialist rare disease clinics.

Amy with her beloved Nick, Mum Jayne and Steve Morgan CBE 2012 – Amy received the ‘Against All Odds’ award.

The visit focused on the benefits of dedicated services that bring together medical expertise, help families better understand their children’s conditions, and support research into future treatments.

For Jayne, the work is deeply personal. Her daughter Amy was diagnosed with Cockayne syndrome and sadly died in 2020. Through Amy and Friends, Jayne continues to support families affected by Cockayne syndrome and related disorders, with more than 1,000 families receiving help across the UK.

Jayne played an instrumental role in helping NHS England understand the needs of people living with these rare conditions and their families, highlighting the importance of specialist care, clearer information and opportunities to contribute to medical research.

A key partnership began several years ago when she met Dr Shehla Mohammed, of Guy’s and St Thomas’ NHS Foundation Trust.

“Dr Mohammed listened to our families and understood what we needed,” Jayne said. “She then undertook the enormous amount of work needed to turn the vision of a specialist clinic into a reality. We are incredibly grateful for her dedication.”

The UK clinic subsequently provided a blueprint for a second specialist clinic in the Netherlands. Now, Jayne hopes that sharing this experience will help families in Japan access similar care.

Jayne said: “The families we met in Japan are desperate for a dedicated clinic so that their children and young people can receive the specialist medical care they deserve.

“The medical/scientific team, led by Prof Tomoo Ogi, were welcoming and enthusiastic about learning from our experience. There was a real sense of shared purpose: working together to give families better care, better information and greater hope for the future.”

For Jayne, international collaboration is also vital to the search for treatments.

“There is currently no cure for Cockayne syndrome, but we continue to work together in the hope that research, including advances in gene editing, may one day offer new possibilities. Our hope is that future treatments will give our children and young people a better quality of life and, wherever possible, more time with the people who love them. Every improvement matters.”


Skip to content